Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development
about
A Systematic Review of Carcinogenic Outcomes and Potential Mechanisms from Exposure to 2,4-D and MCPA in the EnvironmentNext-generation prognostic assessment for diffuse large B-cell lymphomaThe Tumor Suppressor BCL7B Functions in the Wnt Signaling PathwaySystematic evaluation of apoptotic pathway gene polymorphisms and lung cancer riskEight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanismsIdentification of predictive pathways for non-hodgkin lymphoma prognosisGene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.Targetome profiling and functional genetics implicate miR-618 in lymphomagenesisA microdeletion at 12q24.31 can mimic beckwith-wiedemann syndrome neonatally.Examining racial differences in diffuse large B-cell lymphoma presentation and survival.Genetic variation in cell death genes and risk of non-Hodgkin lymphomaGermline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte developmentHost genetics in follicular lymphomaA comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.TNF-α, a good or bad factor in hematological diseases?Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.Candidate gene association studies and risk of chronic lymphocytic leukemia: a systematic review and meta-analysis.Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma.Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.Genetic Variations of Tumor Necrosis Factor -α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients.Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis.Role of the functional MNS16A VNTR-243 variant of the human telomerase reverse transcriptase gene in progression and response to therapy of patients with non-Hodgkin's B-cell lymphomas.Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
P2860
Q21285085-D7E0B756-8AD6-41B1-BBB6-076FF030EC5AQ26796428-FD10EF2C-BBD3-4A1A-A22F-2AF0A30BFB1DQ27311563-95318C61-4A45-4761-8823-CDFED362EA49Q28391725-1A52153D-F328-4332-919A-A959B242EF89Q28477763-9599096E-E439-49CB-B4DE-E8408EDC31EBQ30497902-8EA4DC77-4B93-4DFA-9D33-2802B8BB2A89Q30584472-A11C78F2-CD02-4FD6-A0A1-87191D90D408Q33779176-96D58148-3294-44B2-B3B4-FB35BED0A492Q33906654-314BE095-7131-46C1-9193-DF42470C6761Q34117972-44059F10-DE18-481D-B820-18B85A54A615Q34162892-C8B9D74A-3B90-4A8C-B8D4-F35A4CBDF758Q34292891-016B45EA-1221-4A2A-BC08-C1A0C5C6B124Q35009957-6DC52C9D-5985-4250-924E-17247791EF4BQ35038312-8D2F166F-5E3C-48C1-9D97-9BA0EDBCE7FCQ35311162-C6454F01-0725-4246-8907-4AA05883CFAAQ36306403-60FF5A2D-E986-4D4C-B82E-352E0009994AQ36440086-BB4E6A79-EC99-4921-B80F-50AF81D0CF6AQ36618819-E4B944E2-C4EE-4FC3-972E-A8CE906F171CQ37043776-F99A914D-6E8F-4B83-A118-5D8506F208C1Q37280599-0069542F-7C66-4EC1-9610-5FB9D0C77435Q37716643-4CAD2932-B929-47C2-8B02-F1A5476DE799Q38104390-2AFE82AA-949D-4067-AD42-B13375BBDFFDQ38516259-C5CBF56A-9E17-4EA8-ACA2-88A4C2DDEDD9Q39727079-5584BC60-5A75-4709-9138-6163291E5523Q41854152-5CC29479-9E16-4D5E-8922-CC8ECF7A85BEQ41894251-15D45595-0CD4-45EF-B203-275951578AB1Q44058153-36E22AED-5C39-4B06-8304-27FB7CEB214EQ46786327-5D21C50B-CC08-441B-8A77-CADF64D1443EQ53260519-20AE2759-52CE-4BE2-B4CE-0E243171D249
P2860
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@ast
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@en
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@nl
type
label
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@ast
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@en
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@nl
prefLabel
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@ast
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@en
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@nl
P2093
P2860
P50
P1476
Risk of non-Hodgkin lymphoma a ...... is, and lymphocyte development
@en
P2093
Andrew Grulich
Anne Kricker
Brian Leaderer
Lindsay M Morton
Richard K Severson
Scott Davis
Shelia Hoar Zahm
Sophia S Wang
Tongzhang Zheng
P2860
P304
P356
10.1158/1055-9965.EPI-08-1037
P50
P577
2009-03-31T00:00:00Z